Colon Cancer
A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with Telisotuzumab Adizutecan in Subjects with Metastatic Colorectal Cancer (AndroMETa-CRC-533) (M24-533)
- Details
ClinicalTrials.gov ID:
NCT06820463
Diagnosis Type:
NA
USOR Number:
- Address
,
P: